Document is current
Any future updates will be listed below
-
Authors
Clemens, Christoph R.
Lauermann, Jost L.
Schmitz, Boris
Eter, Nicole
Alten, Florian
-
Funding
Funding for this research was provided by:
Universitätsklinikum Münster
- License Information
-
More Information
Article History
Received: 13 April 2021
Accepted: 24 August 2021
First Online: 14 September 2021
Competing interests
: Christoph Clemens and Florian Alten are consultants to Bayer, Nicole Eter is a consultant to Heidelberg Engineering, Novartis, Bayer, Sanofi Aventis, Allergan, Bausch and Lomb. Jost Lauermann and Boris Schmitz: None.
